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Abstract
Previous studies have shown that dibutyltin (DBT) interferes with the function of human natural
killer (NK) cells, diminishing their capacity to destroy tumor cells, in vitro. DBT is a widespread
environmental contaminant and has been found in human blood. As NK cells are our primary immune
defense against tumor cells, it is important to understand the mechanism by which DBT interferes
with their function. The current study examines the effects of DBT exposures on key enzymes in the
signaling pathway that regulates NK responsiveness to tumor cells. These include several protein
tyrosine kinases (PTKs), mitogen activated protein kinases (MAPKs) and mitogen activated protein
kinase kinases (MAP2Ks). The results showed that in vitro exposures of NK cells to DBT had no
effect on PTKs. However, exposures to DBT for as little as 10 min were able to increase the
phosphorylation (activation) of the MAPKs. The DBT-induced activations of these MAPKs, appears
to be due to DBT-induced activations of the immediate upstream activators of the MAPKs, MAP2Ks.
The results suggest that DBT-interference with the MAPK signaling pathway is a consequence of
DBT exposures, which could account for DBT-induced decreases in NK function.
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INTRODUCTION
Dibutyltin (DBT) has been used as a stabilizer in polyvinyl chloride (PVC) plastic products
(Roper, 1992) and as a de-worming agent in poultry (Epstein et al., 1991). Due to these uses
it has been found in some plastic food containers (Nakashima et al., 1990; Yamada et al.,
1993) as well as some poultry products (Epstein et al., 1991). DBT has also been found in
drinking water due to leaching from PVC pipes (Sadiki et al., 1996). Human exposure to DBT
could result from poultry products (Epstein et al., 1991), consuming beverages stored in PVC
pipes during manufacture (Forsyth et al., 1992a,b), and drinking water (Sadiki et al., 1996).
DBT has been found in human blood from donors with no known route of exposure other than
what is found in the environment (Kannan et al., 1999; Whalen et al., 1999). A Danish study
found DBT in liver samples from eighteen deceased Danish males who had no documented
exposure to DBT (Nielsen and Strand, 2002).
DBT appears to cause a variety of birth defects in rats and to disrupt normal embryonic
development (Ema et al., 1996; Noda et al., 1993). Thymus atrophy and pancreatitis are
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consequences of DBT exposure in rats (Merkord et al., 1997; Pieters et al., 1994). Exposure
of animals to DBT may debilitate their immune function, rendering them more vulnerable to
infectious diseases (Kannan et al. 1997, 1998).
The innate immune system includes natural killer (NK) lymphocytes, which have a critical role
in protecting the body against viral infections and tumor growth (Trinchieri, 1989; Biron,
1997). Therefore, suppressing their cytotoxic function could debilitate the immune system’s
ability to eradicate viral infections and tumors. In previous studies we have shown that exposure
of human NK cells to DBT, in vitro, causes a very significant suppression of their ability to
kill tumor cells (Dudimah et al., 2007; Whalen et al., 1999; Whalen et al., 2002)
When an NK cell binds to a target cell, non-receptor protein tyrosine kinases (PTKs) are
activated (Gismondi et al., 2000). Activation of PTKs causes activation of guanine nucleotide
exchange factors (GEFs), and subsequent activation of small GTP-binding (G) proteins (Vivier
et al., 2004; Djeu et al., 2002). Activation of small G-proteins lead to activation of mitogen-
activated protein kinases (MAPKs), which include p44/42 (also known as ERK1/2), p38, and
JNK. Activation of p44/42 appears to be a part of the mechanism which controls the release
of cytotoxic granules (Trotta et al., 1998, Trotta et al., 2000, Wei et al., 1998). p38 and JNK
appear to regulate the responsiveness of the NK cell (Trotta et al., 2000; Chan et al., 2001).
MAPKs are activated by phosphorylation catalyzed by mitogen-activated protein kinase
kinases (MAP2Ks). p44/42 is activated by an upstream MAP2K, MEK1/2 (Derijard et al.,
1995; Payne et al., 1991; Han et al., 1996) while p38 is activated by MKK3/6 (Han et al.,
1996). MAP2Ks are activated by mitogen-activated protein kinase kinase kinases (MAP3Ks)
(Vivier et al., 2004).
As DBT has been shown to suppress human NK function, it is important to delineate the
mechanism by which this suppression occurs. Activation of any of the enzymes of the above
described pathway, such as MAPKs, by DBT would leave the NK cell unable to respond to
subsequent target cell contact, as the enzyme(s) would not be available for activation by target
cells. It is known that prior activation of the enzymes of the cytotoxic pathway leaves the NK
cell unable to respond to subsequent target cell encounters (anergic) (Jewett and Bonavida,
1995).
In the previous studies we have shown that exposure of NK cells to another organotin
compound, tributyltin (TBT), caused activation of the MAPKs, p44/42, p38, and JNK (Aluoch
and Whalen, 2005; Aluoch et al., 2006; Aluoch et al., 2007). Here we investigate the effects
of exposures to DBT on the activation states of PTKs, MAP2Ks, and MAPKs in human NK
cells.
MATERIALS AND METHODS
Isolation of NK cells
Peripheral blood from healthy adult (male and female) volunteer donors was used for this study
(American Red Cross, Portland OR, Key Biologics, Memphis, TN). Highly enriched NK cells
were obtained using a rosetting procedure. The buffy coats were fresh having been collected
within 24 h of the NK-cell isolation procedure. Buffy coats were mixed with 0.6–1 mL of
RosetteSep human NK cell enrichment antibody cocktail (StemCell Technologies, Vancouver,
British Columbia, Canada) per 45 mL of buffy coat. The mixture was incubated for 30 min at
room temperature (~ 25° C). Following the incubation, 6–8 mL of the mixture was layered
onto 4 mL of Ficoll-Hypaque (1.077 g/mL) (Sigma) and centrifuged at 1200 g for 30–40 min.
The cell layer was collected and washed twice with PBS (phosphate buffered saline, pH 7.2)
and stored in complete media (RPMI-1640 supplemented with 10% heat-inactivated BCS
(bovine calf serum), 2 mM L-glutamine and 50 U penicillin G with 50 µg streptomycin/ml) at
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1 million cells/mL. The resulting cell preparation was >95% CD16+, 0% CD3+ by fluorescence
microscopy (Whalen et al., 2002).
Chemical Preparation
Dibutyltin was purchased from Aldrich Chemical Co. (Milwaukee,WI). A DBT stock solution
was prepared by dissolving DBT in dimethylsulfoxide (DMSO). This DBT stock solution was
diluted media to achieve final concentrations of 10-0.5 µM.
Cell Lysates
NK cells were treated with 10-0.5 µM DBT or control for 10 min, 60 min, or 6 h. Following
the treatments, the cells were centrifuged and the cell pellets were lysed using 500 µL of lysis
buffer (Active motif, Carlsbad, CA) per 10 million cells. The cell lysates were stored frozen
at −80°C up to the point when they were run on SDS-PAGE. All controls and DBT-exposed
cells for a given experimental set-up (described above) were from an individual donor. Each
of the experimental set-ups was repeated a minimum of three times using cells from different
donors.
Western Blot
Cell lysates were run on 10% SDS-PAGE (sodium dodecylsulfate polyacrylamide gel
electrophoresis) and transferred to PVDF (polyvinylidene Difluoride) membrane. The PVDF
was immunoblotted with specific primary antibodies listed in table 1. Antibodies were
visualized using the ECL chemiluminescent detection system (Amersham, Piscataway, NJ)
and a Kodak Image Station (Kodak, Rochester, NY). The density of each protein band was
determined by densitometric analysis using the Kodak Image Station analysis software. The
settings on the image station were optimized to detect the largest possible signal range and to
prevent saturation of the system. A given experimental set-up (as described in the cell lysate
section) always had its own internal control. Thus, differences in phosphorylation state and
changes in protein expression were determined relative to the internal control. This
determination provided relative quantitation by evaluating whether a given treatment altered
these enzymes/proteins relative to untreated cells. β-actin levels were determined for each
condition to verify that equal amounts of protein were loaded. In addition, the density of each
protein band was normalized to β-actin to correct for small differences in protein loading among
the lanes.
Phosphatase Assay
A serine/threonine phosphatase assay kit was purchased from AnaSpec, Inc. (San Jose, CA).
Total ser/thr phosphatase activity in control and DBT-exposed NK cells was measured by the
addition of 50 µL pNPP reaction mixture containing (12.5 µL of pNPP stock solution (100 ×),
1.24 mL of assay buffer and 3.75 µL of 1M DTT) to the appropriate dilutions of the cell lysates
(50 µL) in the wells of a 96-well plate. The plate was incubated at room temperature and
absorbance was measured at 405 nm in a microplate reader every 5 min for 40 min.
Statistical analysis
Analysis of variance (ANOVA) followed by pairwise comparison of data was carried out for
all studies. A significant ANOVA was followed by pair wise comparisons of control versus
DBT-exposed data using a t-test. A minimum of three separate determinations were carried
out for each Western blot experimental set-up (n≥3) and statistical significance was noted at
p<0.05.
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Effects of 10 min exposures to 10-0.5 µM DBT on phosphorylation of p38 and MKK3/6 in NK
cells
Figure 1 shows the effects of 10 min exposures to DBT on the phosphorylation of p38 and its
immediate upstream activator MKK3/6. Significant increases in phospho-p38 of 1.8, 2.2, 1.8,
1.6 and 1.5-fold (compared to control) were seen at 10, 5 2.5 1 and 0.5 µM DBT, respectively
(p<0.05). The observed activation (phosphorylation) of p38 prompted us to investigate the
effects of DBT on its upstream activator, MKK3/6. Exposure to 10, 5, 2.5, and 0.5 µM DBT
also produced significant increases in phospho-MKK3/6 of 1.8, 1.8, 1.60, and 1.8-fold
compared to control, respectively (p<0.05) (Figure 1). The increases in phosphorylation of
MKK3/6 seen with 1 µM DBT ranged from 1.3 to 2.5-fold with an average value of 1.6-fold,
however due the variability of the increase the p value was greater than 0.05. Thus, for every
p38 activation, there was a corresponding activation of MKK3/6. Figure 1A shows the fold
increases in phosphorylation of p38 and MKK3/6 combined from at least 3 separate
experiments. Figures 1B and 1C show data from representative experiments. The total levels
of p38 and MKK3/6 were not significantly altered by exposures to DBT (data not shown).
Effects of 10 min exposures to 10-0.5 µM DBT on phosphorylation of p44/42 and MEK1/2
Figure 2 shows changes in phospho-p44/42 and phospho-MEK1/2 in NK cells exposed to DBT
for 10 min. Significant increases in phospho-p44/42 of 1.8-fold at 10 µM DBT and 1.6-fold at
5 µM DBT compared to control were seen following 10 min exposures (p<0.05). No significant
activation was seen at 2.5-0.5 µM DBT. There was a corresponding activation of the upstream
activator of p44/42, MEK1/2. Exposure to 10 µM DBT caused a 1.9-fold increase in
phosphorylation of MEK1/2 while 5 µM DBT caused a 2-fold increase (P<0.05). Figure 2A
shows the fold increases in phosphorylation of p38 and MKK3/6 combined from at least 3
separate experiments. Figures 2B and 2C show data from representative experiments. As with
p38 and MKK3/6 there was no significant increase in the total levels of p44/42 or MEK1/2
with DBT exposures (data not shown).
Effects of 10 min exposures to 10-0.5 µM DBT on the phosphorylation of JNK and MKK4
No significant changes in the phosphorylation of JNK or its MAP2K, MKK4 were observed
following 10 min exposures of NK cells to 10-0.5 µM DBT (Figure 3A and B).
Effects of 10 min exposures to 10-0.5 µM DBT on non-receptor protein tyrosine kinases
(PTKs)
No significant activations of any PTKs (Zap-70, Syk, Src or Pyk2) were observed within 10
min of exposure to 10-0.5 µM DBT (Figure 3C).
Effects of 60 min exposures to 10-0.5 µM DBT on p38, MKK3/6, p44/42, MEK1/2, JNK, and
MKK4
Figure 4 shows the effects of 60 min exposures to DBT on the phosphorylation of p38 and its
MAP2K, MKK3/6. Significant increases in phosphorylation of the MAPK, p38, of 2.3, 2.0,
1.8 and 1.5-fold compared to control, were seen at 10, 5, 2.5, and 1 µM DBT, respectively
(p<0.05) (Figure 4A and B). As with 10 min exposures, there were corresponding activations
of MKK3/6. Phosphorylation of MKK3/6 was increased 1.6, 1.6, 1.9 and 1.6-fold compared
to control at 10, 5, 2.5, and 1 µM DBT, respectively (p<0.05) (Figure 4A and C). Again, there
were no increases in the total levels of either p38 or MKK3/6 (data not shown). When NK cells
were exposed to 10-0.5 µM DBT for 1 h there were no significant alterations of the
phosphorylation state of p44/42 or its MAP2K, MEK1/2 (Figure 4D and E). Likewise there
were no significant changes in the total levels of p44/42 (data not shown). No significant
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changes in the phosphorylation of the MAPK, JNK, or its MAP2K, MKK4, were observed
following 60 min exposures of NK cells to 10-0.5 µM DBT (data not shown).
Effects of 6 h exposures to 10-0.5 µM DBT on p38, MKK3/6, p44/42, MEK1/2, JNK, and MKK4
Changes in the phosphorylation state of p38 and MKK3/6 in NK cells exposed to DBT for 6
h are shown in Figure 5A–C. There were significant increases in phospho-p38 (2.2-fold)
compared to control (p<0.05) at 10 µM DBT. There were no significant increases in
phosphorylation seen at any of the other concentrations. Exposure to 10 µM DBT also
significantly increased the phosphorylation of MKK3/6 (1.5-fold). Again there were no
significant changes in the total levels of p38 or MKK3/6. In contrast to the results seen with a
6 h exposure to DBT, there was a very substantial increase in the phosphorylation of p44/42
at the 10 µM concentration (4.6 fold) (Figure 5D and E). The immediate upstream activator of
p44/42, MEK1/2, was activated 1.6 fold after a 6 h exposure to 10 µM DBT (Figure 5D and
F). Consistent with the 10 min and 60 min results, there were no significant changes in the
phosphorylation of JNK or MKK4 following 6 h exposures of NK cells to 10-0.5 µM DBT
(data not shown).
Effect of DBT on MAPK phosphatase activity
Although we saw activation of MAP2Ks at every concentration of DBT that caused activation
of MAPKs, it was also possible that increased phosphorylation of MAPKs could at least in
part be due to DBT-induced decreases in MAPK phosphatase activity. Thus, lysates from NK
cells treated with 10-0.5 µM DBT for 10 min at 37°C were used to measure the activity of ser/
thr phosphatase activity. MAPK phosphatases are ser/thr phosphatases so this assay indicated
whether DBT exposures were able to decrease MAPK phosphatase activity which could have
also accounted for the observed increases in MAPK phosphorylation. The results indicate that
there was no significant difference among the treatments as compared to control (data not
shown). Thus, these results indicate that DBT exposure is not inhibiting MAPK phosphatase
activity.
DISCUSSION
We have previously shown that DBT has the ability to significantly disrupt human NK cell
lytic function, in vitro (Whalen et al., 1999, 2002, Dudimah et al., 2007). It was evident in
those studies that a 1 h exposure to as little as 0.5 µM DBT induced permanent and progressive
loss of NK lytic ability when the cells were placed in DBT-free media for as long as 6 days.
Levels of DBT in human blood have been found to range from undetectable to as high as 0.31
µM (Kannan et al., 1999; Whalen et al., 1999). Our previous studies have also shown that there
is a loss of cell surface protein expression and of cytolytic proteins (granzyme B and perforin)
that accompany this loss of lytic function (Odman-Ghazi et al. 2003; Catlin et al., 2005). In
this study we examine the effects of DBT exposures on several enzymes whose functions are
key to regulating NK cell function, in an effort to elucidate the mechanism by which DBT
causes NK cells to lose function. We have shown that another butyltin compound, TBT, which
also decreases NK function, causes alterations of some of these key enzymatic activities
(Aluoch and Whalen, 2005; Aluoch et al., 2006; Aluoch et al. 2007). Specifically, MAPKs and
MAP2Ks were activated by TBT exposures. MAPKs are regulators of the lytic response of
NK cells (Vivier et al. 2004). Activation of these enzymes by TBT leaves the NK cell incapable
of responding to an appropriate target cell, due to the fact that the MAPKs have been previously
activated and are unavailable for activation by the target (Dudimah et al, 2009).
In this study we found that 10 min exposures to DBT caused activation of the MAPK, p38, at
every concentration tested. This activation was accompanied by an activation of the enzyme
that activates p38, the MAP2K, MKK3/6. This same length of exposure to DBT did not activate
Odman-Ghazi et al. Page 5













the MAPK, JNK. However, it did activate p44/42 and its MAP2K, MEK1/2, but only at the
two highest concentrations of DBT. After 1 h there remained a significant increases in
phosphorylation of p38 and MKK3/6 at all but the lowest DBT concentration, but there was
no longer a significant activation of p44/42. The DBT-induced activations of p38 and MKK3/6
maintained out to 6 h, but they were only significant at the 10 µM concentration. Interestingly,
after a 6 h exposure to 10 µM DBT there was a very significant activation of p44/42. Thus, the
ability of DBT to activate p38 diminished with length of exposure, which was similar to what
was seen when NK cells were exposed to TBT (Aluoch et al., 2006). Unlike p38, the activation
of p44/42 by DBT was greatest at a 6 h exposure. p38 appears to be the most sensitive of the
MAPKs to DBT exposures, as even the 0.5 µM concentration caused increased
phosphorylation of p38 at 10 min of exposure. This result is in contrast to that seen with TBT
exposures, where p44/42 was the most sensitive MAPK (Aluoch et al. 2006)
The activations of MAP2K, MKK3/6 and MEK1/2 due to a 10 min exposure to DBT suggested
an involvement of either MAP3Ks or MAP2K phosphatases. To begin to elucidate how DBT
activates MKK3/6 and MEK1/2, we have assessed DBT effect(s) on the most upstream
signaling proteins in this pathway, the PTKs. NK cell exposure to DBT for 10 min did not
significantly activate ZAP-70, Syk, Src or PYK2. Thus, DBT-induced activation of either
MKK3/6 or MEK1/2 does not appear to be a result of PTK activation leading to MAP3K
activation. However, the accumulation of the phosphorylated MKK3/6 and MEK1/2 may be
due to direct DBT-induced activation of the immediate upstream activator of the MAP2Ks,
MAP3Ks (such as Raf-1) (Pearson et al., 2001) and/or DBT-induced inhibition of the enzymes
responsible for dephosphorylating the MAP2Ks, MAP2K phosphatases (Camps et al., 2000;
Mao et al., 2005). Physiologically, target cell binding inactivates NK cells with persistent
parallel loss of phosphatase activity (Bajpai and Brahmi, 1994). Pharmacological Ser/Thr
phosphatase inhibitors also inhibit cytotoxic function (Bajpai and Brahmi, 1994). Inhibition
of protein phosphatases, which inactivate MAPKs and MAP2Ks (Gomez and Cohen, 1991;
Anderson et al., 1990; Ishihara et al., 1989) will lead to activation of MAP2Ks and MAPKs.
We addressed this possibility using a phosphatase assay and found that there was no DBT-
induced alteration of phosphatase activity. This suggests that the increase in MAP2K and
MAPK phosphorylation seen with DBT are not due to inhibition of phosphatase activity and
thus may be due to direct DBT-induced activation of MAP3Ks. Studies examining the ability
of DBT to activate MAP3Ks (Rafs, ASK-1) using direct assay of MAP3K kinase activity are
underway.
This study has widened our understanding of how an initial exposure to a range of DBT
concentrations can cause inhibition of cytotoxic function: (1) DBT (10-0.5 µM) can
significantly activate both p38 and p44/42 within 10 min of exposure; (2) activation of p38 by
10-0.5 µM DBT can be accounted for by DBT-induced activation of its upstream activator
MKK3/6; (3) activation of p44/42 by 10 and 5 µM DBT can be accounted for by DBT-induced
activation of its upstream activator MEK1/2; (4) activation of p38 and MKK3/6 by 0.5 µM
DBT lasts less than 1 h while their activation by 10-1 µM DBT can last for at least 1 h, only
the activation seen at 10 µM DBT maintains for 6 h; (5) activation of p44/42 and MEK1/2 by
10 and 5 µM DBT lasts less than 1 h while their activation by 10 µM DBT returns by 6 h; (6)
at all concentrations of DBT where MAPKs were activated, inhibition of cytotoxic function
was also seen(Dudimah et al, 2007) ; (7) DBT-induced activation of MAPKs and MAP2Ks is
not due to DBT-induced activation of the most upstream signaling proteins in this pathway,
PTKs.
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Effects of 10 min exposures to 10 to 0.5 µM DBT on phospho-p38, and phospho-MKK3/6 in
NK cells: (A) levels of phospho-p38 and phosph-MKK3/6 normalized to control in pure NK.
Values are mean ± S.D. from at least three separate experiments using cells from different
donors * indicates significant difference compared to the control (p<0.05). (B) Representative
experiment for phospho-p38. The density values (arbitrary units) for phospho-p38 in this
representative blot were: control=26399; 10 µM=52511; 5 µM=56184; 2.5 µM=48658;1
µM=54985; 0.5 µM=35931. These values are raw values and have not been corrected for
loading differences (by normalization to actin). (C) Representative experiment for phospho-
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MKK3/6. The density values for phospho-MKK3/6 in this representative blot were:
control=48613; 10 µM=72130; 5µM=83952; 2.5 µM=54372; 1 µM=53313; 0.5 µM=43310.
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Effects of 10 min exposures to 10 and 5 µM DBT on phospho-p44/42, and phospho-MEK1/2
in NK cells: (A) levels of phospho-p44/42 and phosph-MEK1/2 normalized to control. Values
are mean ± S.D. from at least three separate experiments using cells from different donors*
indicates significant difference compared to the control (p<0.05). (B) Representative
experiment for phospho-p44/42. The density values (arbitrary units) for phospho-p44/42 in
this representative blot were: control=11780; 10 µM=30551; 5µM=27244; 2.5 µM=26660; 1
µM=15345; 0.5 µM=16234. (C) Representative experiment for phospho-MEK1/2. The density
values for phospho-MEK1/2 in this representative blot were: control=46842; 10 µM=85910;
5µM=80800; 2.5 µM=50317; 1 µM=74064; 0.5 µM=37678.
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Effects of 10 min exposures to 10 to 0.5 µM DBT on phosphorylation of JNK, MKK4, and
Protein tyrosine kinases (Syk, ZAP-70, Pyk and Src ) in NK cells. (A) Representative
experiment of phospho-JNK. (B) Representative experiment of phospho-MKK4. (C)
Representative experiment for phospho-Syk, phospho-ZAP-70, phospho-Pyk and phospho-
Src.
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Effects of 60 min exposures to 10 to 0.5 µM DBT on phospho-p38, phospho-MKK3/6,
phospho-p44/42, and phospho-MEK1/2 in NK cells: (A) levels of phospho-p38 and phospho-
MKK3/6 normalized to control* indicates significant difference compared to the control
(p<0.05). Values are mean ± S.D. from at least three separate experiments using cells from
different donors. (B) Representative experiment for phospho-p38. (C) Representative
experiment for phospho-MKK3/6. (D) Representative experiment for phospho-p44/42. (E)
Representative experiment for phospho-MEK1/2.
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Effects of 6 hour exposures to 10 µM DBT on phospho-p38, phospho-MKK3/6, phospho-
p44/42, and phospho-MEK1/2 in NK cells: (A) levels of phospho-p38 and phospho-MKK3/6
normalized to control* indicates significant difference compared to the control(p<0.05) Values
are mean ± S.D. from at least three separate experiments using cells from different donors. (B)
Representative experiment for phospho-p38. (C) Representative experiment for phospho-
MKK3/6. (D) levels of phospho-p44/42 and phospho-MEK1/2 normalized to control. Values
are mean ± S.D. from at least three separate experiments using cells from different donors. (E)
Representative experiment for phospho-p44/42. (F) Representative experiment for phospho-
MEK1/2.
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TABLE 1
Antibodies used in Western blot analysis
Antibody Specificity
Anti-phospho-p38 Human p38 phosphorylated on T180 and Y182
Anti-p38 Human p38
Anti-phospho-p44/42 Human p44/42 phosphorylated on T202 and Y204
Anti-p44/42 Human p44/42
Anti-phospho-MKK3/6 Human MKK3/6 phosphorylated on S189 and S207
Anti-MKK3/6 Human MKK3/6
Anti-phospho-MEK1/2 Human MEK1/2 phosphorylated on S217/S221
Anti-MEK1/2 Human MEK1/2
Anti-phospho-Src (Tyr416) Human Src phosphorylated on Y416
Anti-phospho-Pyk2 (Tyr402) Human Pyk2 phosphorylated on Y402
Anti-phospho-Syk (Tyr525/526) Human Syk phosphorylated on Y525 andY526
Anti-phospho-Zap-70 (Tyr319), Human Zap-70 phosphorylated on Y319
Anti-β-actin Human β-actin
All antibodies were obtained from Cell Signaling Technologies, Beverly, MA
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